Compile Data Set for Download or QSAR
Report error Found 32 Enz. Inhib. hit(s) with all data for entry = 50019864
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623868(CHEMBL5433816)
Affinity DataIC50: 37nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623866(CHEMBL5422460)
Affinity DataIC50: 38nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623867(CHEMBL5402945)
Affinity DataIC50: 55nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623864(CHEMBL5438053)
Affinity DataIC50: 73nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623865(CHEMBL5422732)
Affinity DataIC50: 86nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623862(CHEMBL5406099)
Affinity DataIC50: 103nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM19187(CHEMBL396778 | (2S)-2-[({4-[(3-fluorophenyl)methox...)
Affinity DataIC50: 260nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623869(CHEMBL5437538)
Affinity DataIC50: 833nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623857(CHEMBL5398332)
Affinity DataIC50: 948nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623861(CHEMBL5413841)
Affinity DataIC50: 1.93E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623856(CHEMBL5420059)
Affinity DataIC50: 2.25E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623860(CHEMBL5400073)
Affinity DataIC50: 2.78E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623857(CHEMBL5398332)
Affinity DataIC50: 3.54E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623859(CHEMBL5415952)
Affinity DataIC50: 4.55E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623867(CHEMBL5402945)
Affinity DataIC50: 4.89E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623865(CHEMBL5422732)
Affinity DataIC50: 4.91E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623856(CHEMBL5420059)
Affinity DataIC50: 4.94E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623855(CHEMBL5404106)
Affinity DataIC50: 5.01E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623859(CHEMBL5415952)
Affinity DataIC50: 5.91E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623855(CHEMBL5404106)
Affinity DataIC50: 6.20E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623858(CHEMBL5403156)
Affinity DataIC50: 6.21E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623863(CHEMBL5438218)
Affinity DataIC50: 7.39E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623858(CHEMBL5403156)
Affinity DataIC50: 9.50E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM19187(CHEMBL396778 | (2S)-2-[({4-[(3-fluorophenyl)methox...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623869(CHEMBL5437538)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623860(CHEMBL5400073)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition an...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623868(CHEMBL5433816)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623866(CHEMBL5422460)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623864(CHEMBL5438053)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623863(CHEMBL5438218)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623862(CHEMBL5406099)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Hec Pharm Group

Curated by ChEMBL
LigandPNGBDBM50623861(CHEMBL5413841)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/17/2024
Entry Details
PubMed